Comparing ASCT Followed by Anti-BCMA CAR-T vs. ASCT Alone in NDMM Patients Eligible for ASCT

NCT06963866 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma, Newly Diagnosed

Interventions

BIOLOGICAL: autologous stem cell transplantation
BIOLOGICAL: CAR-T

Sponsor

Xuzhou Medical University